Understanding the Recent Policy Changes and Their Impact
The modern industrial policy, which goes beyond mere rhetoric to achieve tangible economic development, is built on clear rules and well-defined incentive mechanisms. In this context, the recent publication in the Federal Official Gazette (DOF) of the Agreement establishing rules for determining, accrediting, and verifying National Content represents a significant step towards regulatory maturity.
This instrument, far from being a mere administrative procedure, provides legal certainty to a concept crucial for sustainable healthcare and the strengthening of the domestic market. This update is timely for strategic manufacturing sectors, such as pharmaceuticals and medical devices, given the convergence of factors like nearshoring, reconfiguration of global supply chains, and a federal administration focused on self-sufficiency.
Transition from General Criteria to Specific Methodologies
One of the most significant advances in this new agreement is the shift from general criteria to specific methodologies. For years, the determination of National Content (CN) operated under interpretive margins that made compliance difficult for companies and oversight challenging for authorities. Now, the Anti-Corruption and Good Governance Secretariat presents a technical roadmap that allows for precise mathematical calculation of each link’s contribution to the final product.
This definition is vital for eliminating uncertainty. By establishing clear rules on how inputs, labor, and technological processes performed domestically are accredited, companies are encouraged to review and deepen their local integration. Compliance is no longer just a matter of honest declaration but understanding domestic procurement as a structural competitive advantage.
Alignment with the Public Procurement Law for the Public Sector (LAASSP)
The relevance of this Agreement is magnified when analyzing its alignment with the LAASSP. Both regulations act as cogs of the same development motor.
Article 28 of the LAASSP prioritizes national goods in public tenders, reserving certain purchasing processes exclusively for companies meeting the required level of national content (usually 65%). However, without the newly published calculation rules, this article lacked operational force. Now, Article 14 of the same Law, which grants preferential margins to national industry, gains full applicability and enforceability.
This sends a clear signal to investors: the Mexican state is determined to use its purchasing power—embodied in health sector consolidated acquisitions—as a lever to recognize those generating value, employment, and technological transfer in the country. The playing field is leveled, allowing domestically established industry to compete under commercial competitiveness conditions. This does not hinder access to bidding processes for those importing finished products due to economies of scale but opens the market to a more competitive environment.
Opportunities for the Medical Devices Industry
For the medical devices industry, where Mexico is already a global export leader, this regulatory framework opens an opportunity window to look inward. Many companies operating under export manufacturing schemes now have a clear incentive to integrate local secondary and tertiary suppliers—resin manufacturers, electronic components, specialized packaging, and engineering services.
By complying with the new accreditation rules, these companies not only diversify their market accessing government purchases but also strengthen the country’s technological ecosystem.
Implications for the Pharmaceutical Sector
The Agreement offers a sophisticated reading of the productive reality. While global dependency on active pharmaceutical ingredients (APIs) from other regions is a structural challenge, the regulation allows valuing and recognizing complex physical-chemical transformation, formulation, and conditioning processes carried out in Mexico.
This is an implicit recognition of the installed infrastructure. It acknowledges companies maintaining operational plants, investing in quality systems, employing Mexican chemists and technicians, and complying with Cofepris health regulations. The rule accurately distinguishes between mere commercialization and industrial production, strengthening those companies betting on long-term productive investment.
Implementation and Public-Private Collaboration
The effectiveness of this public policy will depend on its implementation. Authorities face the crucial task of verification, a process that must be technical, transparent, and efficient. It’s a demanding task.
Here lies the necessity for public-private collaboration. The organized industry should be a proactive ally of authority, facilitating technical information and promoting best practices to ensure rigorous National Content accreditation verification. Robust verification benefits everyone: it protects formal industry, ensures the quality of healthcare inputs, and guarantees that public funds serve their dual function of attending to the population and stimulating the economy.
Key Questions and Answers
- What is the significance of the recently published agreement in Mexico? The agreement provides legal certainty to National Content, a crucial concept for sustainable healthcare and domestic market strengthening. It introduces specific methodologies for determining National Content, moving away from vague general criteria.
- How does this agreement align with existing laws? The agreement aligns with the Public Procurement Law for the Public Sector (LAASSP), prioritizing national goods in public tenders and granting preferential margins to the national industry.
- What opportunities does this agreement present for the healthcare industry? It encourages local integration and diversification of markets, particularly for the medical devices industry. For the pharmaceutical sector, it recognizes domestic production’s value despite global dependencies.
- What role does implementation and public-private collaboration play? Effective implementation requires rigorous verification, which benefits from public-private collaboration. The organized industry can provide technical information and promote best practices for robust verification.
